Literature DB >> 28169189

Ovarian stimulation protocols for IVF: is more better than less?

Michael M Alper1, Bart C Fauser2.   

Abstract

Conventional ovarian stimulation protocols for IVF are designed to achieve maximum oocyte yields. Conventional protocols, however, are associated with patient discomfort, increased risk of ovarian hyperstimulation syndrome and higher costs. In recent years, mild stimulation protocols have risen in popularity. These protocols typically use lower doses (≤150 IU/day), shorter duration of exogenous gonadotrophins, or both, compared with conventional protocols, with the goal of limiting the number of retrieved oocytes to less than eight. The pregnancy rate per cycle (fresh embryo transfer only) is lower with mild stimulation compared with conventional stimulation; however, the cumulative pregnancy rate seems to be comparable between the approaches. Reports are conflicting on the effects of mild versus conventional stimulation on embryo quality. This article expands on a live debate held at the American Society for Reproductive Medicine 2015 Annual Meeting to compare the advantages and disadvantages of the 'more is better' (conventional protocol) versus 'less is best' (mild protocol) approaches to ovarian stimulation. Both protocols are associated with benefits and challenges, and physicians must consider the needs of the individual patient when determining the best treatment options. Further prospective studies comparing a variety of outcomes with conventional and mild stimulation are needed.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Assisted reproduction; Gonadotrophin; IVF/ICSI outcome; Ovarian hyperstimulation syndrome; Ovarian stimulation

Mesh:

Substances:

Year:  2017        PMID: 28169189     DOI: 10.1016/j.rbmo.2017.01.010

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  15 in total

1.  An artificial neural network for the prediction of assisted reproduction outcome.

Authors:  Paraskevi Vogiatzi; Abraham Pouliakis; Charalampos Siristatidis
Journal:  J Assist Reprod Genet       Date:  2019-06-19       Impact factor: 3.412

2.  Embryo Banking with Mild Ovarian Stimulation for IVF: An Alternative Strategy for Poor Prognosis Patients.

Authors:  Ivan Sini; Arie A Polim; Nining Handayani; Adinda Pratiwi; Rosalina Thuffi; Nuraeni Yusup; Arief Boediono
Journal:  J Reprod Infertil       Date:  2020 Jul-Sep

3.  Medroxyprogesterone acetate used in ovarian stimulation is associated with reduced mature oocyte retrieval and blastocyst development: a matched cohort study of 825 freeze-all IVF cycles.

Authors:  Kemal Ozgur; Murat Berkkanoglu; Hasan Bulut; Levent Donmez; Kevin Coetzee
Journal:  J Assist Reprod Genet       Date:  2020-07-22       Impact factor: 3.412

4.  Delayed Start Protocol with Gonadotropin-releasing Hormone Antagonist in Poor Responders Undergoing In Vitro Fertilization: A Randomized, Double-blinded, Clinical Trial.

Authors:  Afsoon Zarei; Mohammad Ebrahim Parsanezhad; Maryam Azizi Kutenaei; Bahia Namavar Jahromi; Parastoo Soheil Esfahani; Pardis Bakhshaei
Journal:  Oman Med J       Date:  2018-11

5.  The ovulation trigger-OPU time interval of different ovarian protocols in ART: a retrospective study.

Authors:  Xi Shen; Hui Long; Wenya Guo; Yating Xie; Hongyuan Gao; Jie Zhang; Yun Wang; Qifeng Lyu; Yanping Kuang; Li Wang
Journal:  Arch Gynecol Obstet       Date:  2020-06-03       Impact factor: 2.344

Review 6.  Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment.

Authors:  Filippo Maria Ubaldi; Danilo Cimadomo; Alberto Vaiarelli; Gemma Fabozzi; Roberta Venturella; Roberta Maggiulli; Rossella Mazzilli; Susanna Ferrero; Antonio Palagiano; Laura Rienzi
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-20       Impact factor: 5.555

7.  Prognostic role of follicular fluid tumor necrosis factor alpha in the risk of early ovarian hyperstimulation syndrome.

Authors:  Miaad Jabbar Alhilali; Abbas Parham; Armin Attaranzadeh; Malihe Amirian; Mohammad Azizzadeh
Journal:  BMC Pregnancy Childbirth       Date:  2020-11-12       Impact factor: 3.007

Review 8.  Untapped Reserves: Controlling Primordial Follicle Growth Activation.

Authors:  Amanda Kallen; Alex J Polotsky; Joshua Johnson
Journal:  Trends Mol Med       Date:  2018-02-13       Impact factor: 11.951

9.  Live Birth in Woman With Premature Ovarian Insufficiency Receiving Ovarian Administration of Platelet-Rich Plasma (PRP) in Combination With Gonadotropin: A Case Report.

Authors:  Chao-Chin Hsu; Leonard Hsu; Isabel Hsu; Yi-Jen Chiu; Sonam Dorjee
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-19       Impact factor: 5.555

10.  Relationship between follicular size and developmental capacity of oocytes under controlled ovarian hyperstimulation in assisted reproductive technologies.

Authors:  Isao Tamura; Mai Kawamoto-Jozaki; Taishi Fujimura; Yumiko Doi-Tanaka; Haruka Takagi; Yuichiro Shirafuta; Yumiko Mihara; Toshiaki Taketani; Hiroshi Tamura; Norihiro Sugino
Journal:  Reprod Med Biol       Date:  2021-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.